Guru Sonpavde - Concepedia

Author

Guru Sonpavde

Also Known As

Alberto Muñoz, André Fortin, Bellmunt, Joaquim, Drolen, Claire E, G Sonpavde, G. Sonpavde, G.P. Sonpavde, Galsky, Matthew D, Gura Sonpavde, Guru P. Sonpavde

1.1K

Publications

26.8K

Citations

H-Index

143

Concepts

All Affiliations

Dana-Farber Cancer Institute University of Alabama at Birmingham Harvard University Baylor College of Medicine Icahn School of Medicine at Mount Sinai

About

Guru Sonpavde is an author at Dana-Farber Cancer Institute specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	145	7.5K
2	Health Sciences	15	24	1.1K
3	Public Health	9	9	860
4	Engineering	4	4	114
5	African American Studies	1	1	26

Guru Sonpavde

262

Publications

16K

Citations

H-Index

Page 1

	Year	Citations
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma Thomas Powles, Jonathan E. Rosenberg, Guru Sonpavde, New England Journal of Medicine	2021	1.1K
Prostate Cancer, Version 1.2016 James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Journal of the National Comprehensive Cancer Network UrologySurgical OncologyCancer EpidemiologyHealth PolicyGenitourinary Cancer	2016	650
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Journal of the National Comprehensive Cancer Network	2017	573
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients Guillermo de Velasco, Youjin Je, Dominick Bossé, Cancer Immunology Research	2017	459
Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles, New England Journal of Medicine	2023	421
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy Matthew D. Galsky, Noah M. Hahn, Jonathan E. Rosenberg, The Lancet Oncology UrologyMetastatic Urothelial CarcinomaCisplatin-based ChemotherapyGenitourinary CancerMedicine	2011	334
Prostate Cancer, Version 2.2014 James L. Mohler, Philip W. Kantoff, Andrew J. Armstrong, Journal of the National Comprehensive Cancer Network UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2014	333
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma Matthew D. Galsky, G. J. Chen, William Oh, Annals of Oncology Comparative EffectivenessCarboplatin-based ChemotherapyUrologyOncologyGenitourinary Cancer	2011	289
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes Pier Vitale Nuzzo, Jacob E. Berchuck, Keegan Korthauer, Nature Medicine UrologyGenitourinary CancerKidney ResearchMedicineDna Analysis	2020	277
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Journal of the National Comprehensive Cancer Network Urological ResearchSurgical OncologyUrologyUrologic Cancer EpidemiologyGenitourinary Cancer	2017	276

Page 1